Indication of the Extent of Hepatectomy for Hepatocellular Carcinoma on Cirrhosis by a Simple Algorithm Based on Preoperative Variables | Gastrointestinal Surgery | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.204.227.34. Please contact the publisher to request reinstatement.
1.
Chen  MSLi  JQZheng  Y  et al.  A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma.  Ann Surg 2006;243 (3) 321- 328PubMedGoogle ScholarCrossref
2.
Poon  RTFan  ST Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.  Liver Transpl 2004;10 (2) ((suppl 1)) S39- S45PubMedGoogle ScholarCrossref
3.
Imamura  HSeyama  YKokudo  N  et al.  One thousand fifty-six hepatectomies without mortality in 8 years.  Arch Surg 2003;138 (11) 1198- 1206PubMedGoogle ScholarCrossref
4.
Zimmermann  HReichen  J Assessment of the liver function in the surgical patient. Blumgart  LHFong  Y Surgery of the Liver and Biliary Tract. London, England Saunders2000;35- 64Google Scholar
5.
Makuuchi  MKosuge  TTakayama  T  et al.  Surgery for small liver cancers.  Semin Surg Oncol 1993;9 (4) 298- 304PubMedGoogle ScholarCrossref
6.
Lau  HMan  KFan  STYu  WCLo  CMWong  J Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.  Br J Surg 1997;84 (9) 1255- 1259PubMedGoogle ScholarCrossref
7.
Child  CG  IITurcotte  JG Surgery and portal hypertension. Child  CG III The Liver and Portal Hypertension. Philadelphia, PA Saunders1964;50- 58Google Scholar
8.
Pugh  RNMurray-Lyon  IMDawson  JLPietroni  MCWilliams  R Transection of the oesophagus for bleeding oesophageal varices.  Br J Surg 1973;60 (8) 646- 649PubMedGoogle ScholarCrossref
9.
Malinchoc  MKamath  PSGordon  FDPeine  CJRank  Jter Borg  PC A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.  Hepatology 2000;31 (4) 864- 871PubMedGoogle ScholarCrossref
10.
Kamath  PSWiesner  RHMalinchoc  M  et al.  A model to predict survival in patients with end-stage liver disease.  Hepatology 2001;33 (2) 464- 470PubMedGoogle ScholarCrossref
11.
Freeman  RBWiesner  RHHarper  A  et al.  UNOS/OPTN Liver Disease Severity Score: the new liver allocation system: moving toward evidence-based transplantation policy.  Liver Transpl 2002;8 (9) 851- 858PubMedGoogle ScholarCrossref
12.
Cucchetti  AErcolani  GVivarelli  M  et al.  Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.  Liver Transpl 2006;12 (6) 966- 971PubMedGoogle ScholarCrossref
13.
Teh  SHChristein  JDonohue  J  et al.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.  J Gastrointest Surg 2005;9 (9) 1207- 1215PubMedGoogle ScholarCrossref
14.
Teh  SHNagorney  DMStevens  SR  et al.  Risk factors for mortality after surgery in patients with cirrhosis [published online ahead of print January 25, 2007].  Gastroenterology 2007;132 (4) 1261- 1269PubMedGoogle ScholarCrossref
15.
Grazi  GLErcolani  GPierangeli  F  et al.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.  Ann Surg 2001;234 (1) 71- 78PubMedGoogle ScholarCrossref
16.
Capussotti  LMuratore  AMassucco  PFerrero  APolastri  RBouzari  H Major liver resections for hepatocellular carcinoma on cirrhosis: early and long-term outcomes.  Liver Transpl 2004;10 (2) ((suppl 1)) S64- S68PubMedGoogle ScholarCrossref
17.
Capussotti  LMuratore  AAmisano  MPolastri  RBouzari  HMassucco  P Liver resection for hepatocellular carcinoma on cirrhosis: analysis of mortality, morbidity and survival: a European single center experience.  Eur J Surg Oncol 2005;31 (9) 986- 993PubMedGoogle ScholarCrossref
18.
Otsuka  YDuffy  JPSaab  S  et al.  Postresection hepatic failure: successful treatment with liver transplantation [published online ahead of print January 11, 2007].  Liver Transpl 2008;13 (5) 672- 679Google ScholarCrossref
19.
Belghiti  JCortes  AAbdalla  EK  et al.  Resection prior to liver transplantation for hepatocellular carcinoma.  Ann Surg 2003;238 (6) 885- 892PubMedGoogle ScholarCrossref
20.
Pang  YYStrasberg  SM The Brisbane 2000 terminology of liver anatomy and resections.  HPB 2000;2333- 339Google Scholar
21.
Hanley  JA McNeil  BJ The meaning and use of the area under a receiver operating characteristic (ROC) curve.  Radiology 1982;143 (1) 29- 36PubMedGoogle Scholar
22.
Mullen  JTRibero  DReddy  SK  et al.  Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy.  J Am Coll Surg 2007;204 (5) 854- 862PubMedGoogle ScholarCrossref
23.
Cucchetti  AErcolani  GCescon  M  et al.  Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.  J Am Coll Surg 2006;203 (5) 670- 676PubMedGoogle ScholarCrossref
24.
Arroyo  VColmenero  J Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.  J Hepatol 2003;38 ((suppl 1)) S69- S89PubMedGoogle ScholarCrossref
25.
Biggins  SWRodriguez  HJBacchetti  PBass  NMRoberts  JPTerrault  NA Serum sodium predicts mortality in patients listed for liver transplantation.  Hepatology 2005;41 (1) 32- 39PubMedGoogle ScholarCrossref
26.
Biggins  SWKim  WRTerrault  NA  et al.  Evidence-based incorporation of serum sodium concentration into MELD.  Gastroenterology 2006;130 (6) 1652- 1660PubMedGoogle ScholarCrossref
27.
Merion  RMWolfe  RADykstra  DMLeichtman  ABGillespie  BHeld  PJ Longitudinal assessment of mortality risk among candidates for liver transplantation.  Liver Transpl 2003;9 (1) 12- 18PubMedGoogle ScholarCrossref
28.
Northup  PGBerg  CL Preoperative delta-MELD score does not independently predict mortality after liver transplantation.  Am J Transplant 2004;4 (10) 1643- 1649PubMedGoogle ScholarCrossref
29.
Bambha  KKim  WRKremers  WK  et al.  Predicting survival among patients listed for liver transplantation: an assessment of serial MELD measurements.  Am J Transplant 2004;4 (11) 1798- 1804PubMedGoogle ScholarCrossref
30.
Huo  TIWu  JCLin  HC  et al.  Evaluation of the increase in model for end stage liver disease (ΔMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.  J Hepatol 2005;42 (6) 826- 832PubMedGoogle ScholarCrossref
31.
D’Amico  G Developing concepts on MELD: delta and cutoffs.  J Hepatol 2005;42 (6) 790- 792PubMedGoogle ScholarCrossref
Original Article
January 19, 2009

Indication of the Extent of Hepatectomy for Hepatocellular Carcinoma on Cirrhosis by a Simple Algorithm Based on Preoperative Variables

Author Affiliations

Author Affiliations: Liver and Multiorgan Transplant Unit, Department of Surgery and Transplantation, University of Bologna, Bologna (Drs Cescon, Cucchetti, Grazi, Ercolani, Zanello, Ravaioli, and Pinna); and Unit of Surgical Oncology, Institute for Cancer Research and Treatment, Candiolo, Torino, Italy (Drs Ferrero, Vigan[[ograve]], and Capussotti).

Arch Surg. 2009;144(1):57-63. doi:10.1001/archsurg.2008.522
Abstract

Objective  To produce a model indicating the extent of hepatectomy for hepatocellular carcinoma on cirrhosis based on easily available preoperative data.

Design  Retrospective study based on multicenter prospectively updated databases.

Setting  Two tertiary referral centers specializing in hepatobiliary surgery.

Patients  A total of 466 patients undergoing hepatectomy for hepatocellular carcinoma on cirrhosis between 1995 and 2006.

Main Outcome Measures  To create a decision tree for safe liver resection based on factors affecting irreversible postoperative liver failure (IPLF).

Results  A total of 23 patients (4.9%) developed IPLF. The model for end-stage liver disease (MELD) score (categorized as <9, 9-10, and >10; P < .05 for all comparisons) and extent of hepatectomy were independent predictors of IPLF. In patients with a MELD score of less than 9, the IPLF rate was 0.4%. In patients with a MELD score of 9 or 10, the IPLF rate was 1.2% for resections of less than 1 segment, 5.1% for segmentectomies or bisegmentectomies, and 11.1% for major hepatectomies. In this category of MELD, serum sodium levels identified a low-risk group (sodium ≥140 mEq/L; to convert to millimoles per liter, multiply by 1.0) not experiencing IPLF and a high-risk group (sodium <140 mEq/L) in which resections of less than 1 segment led to an IPLF rate of 2.5% and resections of 1 segment or more led to an IPLF rate of more than 5% (P < .05). In patients with a MELD score of more than 10, the IPLF rate was more than 15% in all types of hepatectomies.

Conclusion  A simple algorithm based on the MELD score and serum sodium level can indicate the maximum tolerable extent of hepatectomy for hepatocellular carcinoma on cirrhosis.

×